Chinese General Practice ›› 2024, Vol. 27 ›› Issue (06): 685-691.DOI: 10.12114/j.issn.1007-9572.2022.0765
Special Issue: 高血压最新文章合集
• Original Research • Previous Articles Next Articles
Received:
2022-09-30
Revised:
2022-12-26
Published:
2024-02-20
Online:
2023-11-21
Contact:
LIU Xiaohui
通讯作者:
刘小慧
作者简介:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2022.0765
公式名称 | 点尿钠测定样本类型 | 24 h尿钠排泄量估测公式 |
---|---|---|
Kawasaki | 清晨空腹第2次尿 | 24 h尿钠排泄量(mmol/d)=16.3×[点尿钠(mmol/L)/点尿肌酐(mg/L)×24 h尿肌酐(mg/d)]0.5 24 h尿肌酐(mg/d)(男)=15.12×体质量(kg)+7.39×身高(cm)-12.63×年龄-79.9 24 h尿肌酐(mg/d)(女)=8.58×体质量(kg)+5.09×身高(cm)-4.72×年龄-74.5 |
INTERSALT | 随机尿 | 24 h尿钠排泄量(mmol/d)(男)=25.46+0.46×点尿钠(mmol/L)-2.75×点尿肌酐(mmol/L)-0.13×点尿钾(mmol/L)+4.1×BMI+0.26×年龄 24 h尿钠排泄量(mmol/d)(女)=5.07+0.34×点尿钠(mmol/L)-2.16×点尿肌酐(mmol/L)-0.09×点尿钾(mmol/L)+2.39×BMI+2.35×年龄-0.03×年龄2 |
Tanaka | 随机尿 | 24 h尿钠排泄量(mmol/d)=21.98×[点尿钠(mmol/L)/点尿肌酐(mg/L)×24 h尿肌酐(mg/d)]0.392 24 h尿肌酐(mg/d)=14.89×体质量(kg)+16.14×身高(cm)-2.04×年龄-2 244.45 |
Table 1 Three equations using spot urine samples to estimate 24-hour urinary sodium excretion
公式名称 | 点尿钠测定样本类型 | 24 h尿钠排泄量估测公式 |
---|---|---|
Kawasaki | 清晨空腹第2次尿 | 24 h尿钠排泄量(mmol/d)=16.3×[点尿钠(mmol/L)/点尿肌酐(mg/L)×24 h尿肌酐(mg/d)]0.5 24 h尿肌酐(mg/d)(男)=15.12×体质量(kg)+7.39×身高(cm)-12.63×年龄-79.9 24 h尿肌酐(mg/d)(女)=8.58×体质量(kg)+5.09×身高(cm)-4.72×年龄-74.5 |
INTERSALT | 随机尿 | 24 h尿钠排泄量(mmol/d)(男)=25.46+0.46×点尿钠(mmol/L)-2.75×点尿肌酐(mmol/L)-0.13×点尿钾(mmol/L)+4.1×BMI+0.26×年龄 24 h尿钠排泄量(mmol/d)(女)=5.07+0.34×点尿钠(mmol/L)-2.16×点尿肌酐(mmol/L)-0.09×点尿钾(mmol/L)+2.39×BMI+2.35×年龄-0.03×年龄2 |
Tanaka | 随机尿 | 24 h尿钠排泄量(mmol/d)=21.98×[点尿钠(mmol/L)/点尿肌酐(mg/L)×24 h尿肌酐(mg/d)]0.392 24 h尿肌酐(mg/d)=14.89×体质量(kg)+16.14×身高(cm)-2.04×年龄-2 244.45 |
指标 | 女性患者(n=91) | 男性患者(n=105) | χ2(t)值 | P值 |
---|---|---|---|---|
年龄(岁) | 63.0±12.1 | 52.3±14.7 | -5.875a | <0.001 |
体质指数(kg/m2) | 26.14±4.15 | 27.49±3.67 | 2.224a | 0.027 |
入院收缩压(mmHg) | 151±20 | 148±19 | -0.950a | 0.343 |
入院舒张压(mmHg) | 79±15 | 85±16 | 2.776a | 0.006 |
24 h平均收缩压(mmHg) | 130±18 | 130±17 | 0.044a | 0.965 |
24 h平均舒张压(mmHg) | 71±11 | 78±13 | 4.151a | <0.001 |
24 h平均心率(bpm) | 69±10 | 71±9 | 1.181a | 0.239 |
夜间血压下降异常[例(%)] | 65(72.2) | 65(63.1) | 1.815 | 0.178 |
糖尿病[例(%)] | 26(28.6) | 27(25.7) | 0.202 | 0.653 |
高脂血症[例(%)] | 65(71.4) | 69(65.7) | 0.736 | 0.391 |
左心室肥厚[例(%)] | 12(13.2) | 12(11.5) | 0.122 | 0.727 |
颈动脉内中膜增厚或斑块[例(%)] | 67(75.3) | 75(75.0) | 0.002 | 0.964 |
吸烟史[例(%)] | 1(1.1) | 59(56.2) | 69.657 | <0.001 |
微量蛋白尿[例(%)] | 28(31.1) | 19(18.1) | 4.488 | 0.034 |
临床蛋白尿[例(%)] | 8(8.8) | 2(1.9) | 4.775 | 0.047 |
点尿钠(mmol/L) | 101.35±49.49 | 134.44±56.54 | 4.350a | <0.001 |
实测24 h尿钠排泄量(mmol/d) | 134.86±62.90 | 193.11±82.00 | 5.458a | <0.001 |
Table 2 Baseline characteristics of enrolled patients with primary hypertension
指标 | 女性患者(n=91) | 男性患者(n=105) | χ2(t)值 | P值 |
---|---|---|---|---|
年龄(岁) | 63.0±12.1 | 52.3±14.7 | -5.875a | <0.001 |
体质指数(kg/m2) | 26.14±4.15 | 27.49±3.67 | 2.224a | 0.027 |
入院收缩压(mmHg) | 151±20 | 148±19 | -0.950a | 0.343 |
入院舒张压(mmHg) | 79±15 | 85±16 | 2.776a | 0.006 |
24 h平均收缩压(mmHg) | 130±18 | 130±17 | 0.044a | 0.965 |
24 h平均舒张压(mmHg) | 71±11 | 78±13 | 4.151a | <0.001 |
24 h平均心率(bpm) | 69±10 | 71±9 | 1.181a | 0.239 |
夜间血压下降异常[例(%)] | 65(72.2) | 65(63.1) | 1.815 | 0.178 |
糖尿病[例(%)] | 26(28.6) | 27(25.7) | 0.202 | 0.653 |
高脂血症[例(%)] | 65(71.4) | 69(65.7) | 0.736 | 0.391 |
左心室肥厚[例(%)] | 12(13.2) | 12(11.5) | 0.122 | 0.727 |
颈动脉内中膜增厚或斑块[例(%)] | 67(75.3) | 75(75.0) | 0.002 | 0.964 |
吸烟史[例(%)] | 1(1.1) | 59(56.2) | 69.657 | <0.001 |
微量蛋白尿[例(%)] | 28(31.1) | 19(18.1) | 4.488 | 0.034 |
临床蛋白尿[例(%)] | 8(8.8) | 2(1.9) | 4.775 | 0.047 |
点尿钠(mmol/L) | 101.35±49.49 | 134.44±56.54 | 4.350a | <0.001 |
实测24 h尿钠排泄量(mmol/d) | 134.86±62.90 | 193.11±82.00 | 5.458a | <0.001 |
患者人群 | 例数 | 24 h尿钠排泄量实测值 | 24 h尿钠排泄量估测值 | t配对值 | P值 |
---|---|---|---|---|---|
女性患者 | 91 | 134.86±62.90 | 194.97±64.55 | -8.786 | <0.001 |
男性患者 | 105 | 193.11±82.00 | 237.44±83.30 | -4.274 | <0.001 |
糖尿病患者 | 53 | 155.70±75.79 | 219.20±87.73 | -4.850 | <0.001 |
非糖尿病患者 | 143 | 168.62±79.77 | 217.03±74.33 | -6.401 | <0.001 |
白蛋白尿患者 | 57 | 152.12±73.94 | 235.92±100.39 | -5.926 | <0.001 |
无蛋白尿患者 | 139 | 169.15±80.23 | 211.96±69.18 | -5.879 | <0.001 |
钠盐摄入量 | |||||
<6.0 g组 | 40 | 67.18±24.42 | 164.38±67.29 | -9.593 | <0.001 |
6.0~8.9 g组 | 51 | 127.33±14.17 | 207.76±75.02 | -7.526 | <0.001 |
9.0~11.9 g组 | 58 | 175.86±14.20 | 243.11±76.48 | -6.442 | <0.001 |
≥12 g组 | 47 | 276.39±49.53 | 242.73±67.03 | 2.659 | 0.011 |
Table 3 The difference and correlation between the estimated 24-hour urinary sodium excretion by Kawasaki equation and the measured value
患者人群 | 例数 | 24 h尿钠排泄量实测值 | 24 h尿钠排泄量估测值 | t配对值 | P值 |
---|---|---|---|---|---|
女性患者 | 91 | 134.86±62.90 | 194.97±64.55 | -8.786 | <0.001 |
男性患者 | 105 | 193.11±82.00 | 237.44±83.30 | -4.274 | <0.001 |
糖尿病患者 | 53 | 155.70±75.79 | 219.20±87.73 | -4.850 | <0.001 |
非糖尿病患者 | 143 | 168.62±79.77 | 217.03±74.33 | -6.401 | <0.001 |
白蛋白尿患者 | 57 | 152.12±73.94 | 235.92±100.39 | -5.926 | <0.001 |
无蛋白尿患者 | 139 | 169.15±80.23 | 211.96±69.18 | -5.879 | <0.001 |
钠盐摄入量 | |||||
<6.0 g组 | 40 | 67.18±24.42 | 164.38±67.29 | -9.593 | <0.001 |
6.0~8.9 g组 | 51 | 127.33±14.17 | 207.76±75.02 | -7.526 | <0.001 |
9.0~11.9 g组 | 58 | 175.86±14.20 | 243.11±76.48 | -6.442 | <0.001 |
≥12 g组 | 47 | 276.39±49.53 | 242.73±67.03 | 2.659 | 0.011 |
患者人群 | rs值 | P值 |
---|---|---|
女性患者 | 0.472 | <0.001 |
男性患者 | 0.195 | 0.047 |
糖尿病患者 | 0.425 | 0.002 |
非糖尿病患者 | 0.386 | <0.001 |
白蛋白尿患者 | 0.409 | 0.005 |
无蛋白尿患者 | 0.401 | <0.001 |
钠盐摄入量 | ||
<6.0 g组 | 0.319 | 0.045 |
6.0~8.9 g组 | -0.016 | 0.913 |
9.0~11.9 g组 | 0.014 | 0.915 |
≥12 g组 | <0.001 | 0.999 |
Table 4 Correlation analysis between estimated 24-hour sodium excretion by Kawasaki equation and measured 24-hour sodium excretion
患者人群 | rs值 | P值 |
---|---|---|
女性患者 | 0.472 | <0.001 |
男性患者 | 0.195 | 0.047 |
糖尿病患者 | 0.425 | 0.002 |
非糖尿病患者 | 0.386 | <0.001 |
白蛋白尿患者 | 0.409 | 0.005 |
无蛋白尿患者 | 0.401 | <0.001 |
钠盐摄入量 | ||
<6.0 g组 | 0.319 | 0.045 |
6.0~8.9 g组 | -0.016 | 0.913 |
9.0~11.9 g组 | 0.014 | 0.915 |
≥12 g组 | <0.001 | 0.999 |
Figure 1 The consistency of measured 24-hour urine sodium excretion and estimated 24-hour urine sodium excretion by Kawasaki equation evaluated by the Bland-Altman plot
患者人群 | 例数 | 24 h尿钠排泄量实测值 | 24 h尿钠排泄量估测值 | t配对值 | P值 |
---|---|---|---|---|---|
女性患者 | 91 | 134.86±62.90 | 107.69±26.42 | 4.678 | <0.001 |
男性患者 | 105 | 193.11±82.00 | 174.89±33.58 | 2.008 | 0.047 |
糖尿病患者 | 53 | 155.70±75.79 | 139.43±48.83 | 1.651 | 0.105 |
非糖尿病患者 | 143 | 168.62±79.77 | 145.26±44.00 | 3.864 | <0.001 |
白蛋白尿患者 | 57 | 152.12±73.94 | 140.23±46.24 | 1.179 | 0.244 |
无蛋白尿患者 | 139 | 169.15±80.23 | 145.15±45.02 | 4.018 | <0.001 |
钠盐摄入量 | |||||
<6.0 g组 | 40 | 67.18±24.42 | 113.23±40.86 | -6.751 | <0.001 |
6.0~8.9 g组 | 51 | 127.33±14.17 | 129.36±43.35 | -0.322 | 0.749 |
9.0~11.9 g组 | 58 | 175.86±14.20 | 155.47±43.61 | 3.311 | 0.002 |
≥12 g组 | 47 | 276.39±49.53 | 170.61±30.58 | 12.260 | <0.001 |
Table 5 The difference and correlation between the estimated 24-hour urinary sodium excretion by INTERSALT equation and the measured value
患者人群 | 例数 | 24 h尿钠排泄量实测值 | 24 h尿钠排泄量估测值 | t配对值 | P值 |
---|---|---|---|---|---|
女性患者 | 91 | 134.86±62.90 | 107.69±26.42 | 4.678 | <0.001 |
男性患者 | 105 | 193.11±82.00 | 174.89±33.58 | 2.008 | 0.047 |
糖尿病患者 | 53 | 155.70±75.79 | 139.43±48.83 | 1.651 | 0.105 |
非糖尿病患者 | 143 | 168.62±79.77 | 145.26±44.00 | 3.864 | <0.001 |
白蛋白尿患者 | 57 | 152.12±73.94 | 140.23±46.24 | 1.179 | 0.244 |
无蛋白尿患者 | 139 | 169.15±80.23 | 145.15±45.02 | 4.018 | <0.001 |
钠盐摄入量 | |||||
<6.0 g组 | 40 | 67.18±24.42 | 113.23±40.86 | -6.751 | <0.001 |
6.0~8.9 g组 | 51 | 127.33±14.17 | 129.36±43.35 | -0.322 | 0.749 |
9.0~11.9 g组 | 58 | 175.86±14.20 | 155.47±43.61 | 3.311 | 0.002 |
≥12 g组 | 47 | 276.39±49.53 | 170.61±30.58 | 12.260 | <0.001 |
患者人群 | rs值 | P值 |
---|---|---|
女性患者 | 0.449 | <0.001 |
男性患者 | 0.124 | 0.209 |
糖尿病患者 | 0.415 | <0.001 |
非糖尿病患者 | 0.472 | <0.001 |
白蛋白尿患者 | 0.392 | 0.006 |
无蛋白尿患者 | 0.466 | <0.001 |
钠盐摄入量 | ||
<6.0 g组 | 0.085 | 0.600 |
6.0~8.9 g组 | 0.006 | 0.965 |
9.0~11.9 g组 | -0.012 | 0.931 |
≥12 g组 | -0.088 | 0.555 |
Table 6 Correlation analysis between estimated 24-hour sodium excretion by INTERSALT equation and measured 24-hour sodium excretion
患者人群 | rs值 | P值 |
---|---|---|
女性患者 | 0.449 | <0.001 |
男性患者 | 0.124 | 0.209 |
糖尿病患者 | 0.415 | <0.001 |
非糖尿病患者 | 0.472 | <0.001 |
白蛋白尿患者 | 0.392 | 0.006 |
无蛋白尿患者 | 0.466 | <0.001 |
钠盐摄入量 | ||
<6.0 g组 | 0.085 | 0.600 |
6.0~8.9 g组 | 0.006 | 0.965 |
9.0~11.9 g组 | -0.012 | 0.931 |
≥12 g组 | -0.088 | 0.555 |
Figure 2 The consistency of measured 24-hour urine sodium excretion and estimated 24-hour urine sodium excretion by INTERSALT equation evaluated by the Bland-Altman plot
患者人群 | 例数 | 24 h尿钠排泄量实测值 | 24 h尿钠排泄量估测值 | t配对值 | P值 |
---|---|---|---|---|---|
女性患者 | 91 | 134.86±62.90 | 161.87±44.05 | -4.524 | <0.001 |
男性患者 | 105 | 193.11±82.00 | 173.81±49.54 | 1.992 | 0.049 |
糖尿病患者 | 53 | 155.70±75.79 | 170.19±54.05 | -1.336 | 0.187 |
非糖尿病患者 | 143 | 168.62±79.77 | 167.51±44.74 | 0.164 | 0.870 |
白蛋白尿患者 | 57 | 152.12±73.94 | 181.17±60.37 | -2.696 | 0.010 |
无蛋白尿患者 | 139 | 169.15±80.23 | 164.15±42.06 | 0.752 | 0.453 |
钠盐摄入量 | |||||
<6.0 g组 | 40 | 67.18±24.42 | 137.89±44.70 | -10.347 | <0.001 |
6.0~8.9 g组 | 51 | 127.33±14.17 | 163.10±46.11 | -5.281 | <0.001 |
9.0~11.9 g组 | 58 | 175.86±14.20 | 185.03±44.83 | -1.438 | 0.156 |
≥12 g组 | 47 | 276.39±49.53 | 179.30±41.07 | 9.808 | <0.001 |
Table 7 The difference and correlation between the estimated 24-hour urinary sodium excretion by Tanaka equation and the measured value
患者人群 | 例数 | 24 h尿钠排泄量实测值 | 24 h尿钠排泄量估测值 | t配对值 | P值 |
---|---|---|---|---|---|
女性患者 | 91 | 134.86±62.90 | 161.87±44.05 | -4.524 | <0.001 |
男性患者 | 105 | 193.11±82.00 | 173.81±49.54 | 1.992 | 0.049 |
糖尿病患者 | 53 | 155.70±75.79 | 170.19±54.05 | -1.336 | 0.187 |
非糖尿病患者 | 143 | 168.62±79.77 | 167.51±44.74 | 0.164 | 0.870 |
白蛋白尿患者 | 57 | 152.12±73.94 | 181.17±60.37 | -2.696 | 0.010 |
无蛋白尿患者 | 139 | 169.15±80.23 | 164.15±42.06 | 0.752 | 0.453 |
钠盐摄入量 | |||||
<6.0 g组 | 40 | 67.18±24.42 | 137.89±44.70 | -10.347 | <0.001 |
6.0~8.9 g组 | 51 | 127.33±14.17 | 163.10±46.11 | -5.281 | <0.001 |
9.0~11.9 g组 | 58 | 175.86±14.20 | 185.03±44.83 | -1.438 | 0.156 |
≥12 g组 | 47 | 276.39±49.53 | 179.30±41.07 | 9.808 | <0.001 |
患者人群 | rs值 | P值 |
---|---|---|
女性患者 | 0.459 | <0.001 |
男性患者 | 0.165 | 0.093 |
糖尿病患者 | 0.377 | 0.005 |
非糖尿病患者 | 0.318 | <0.001 |
白蛋白尿患者 | 0.410 | 0.005 |
无蛋白尿患者 | 0.331 | <0.001 |
钠盐摄入量 | ||
<6.0 g组 | 0.297 | 0.063 |
6.0~8.9 g组 | -0.038 | 0.791 |
9.0~11.9 g组 | -0.022 | 0.874 |
≥12.0 g组 | -0.060 | 0.691 |
Table 8 Correlation analysis between estimated 24-hour sodium excretion by Tanaka equation and measured 24-hour sodium excretion
患者人群 | rs值 | P值 |
---|---|---|
女性患者 | 0.459 | <0.001 |
男性患者 | 0.165 | 0.093 |
糖尿病患者 | 0.377 | 0.005 |
非糖尿病患者 | 0.318 | <0.001 |
白蛋白尿患者 | 0.410 | 0.005 |
无蛋白尿患者 | 0.331 | <0.001 |
钠盐摄入量 | ||
<6.0 g组 | 0.297 | 0.063 |
6.0~8.9 g组 | -0.038 | 0.791 |
9.0~11.9 g组 | -0.022 | 0.874 |
≥12.0 g组 | -0.060 | 0.691 |
钠盐摄入量 | 例数 | K法24 h尿钠排泄量估测值的相对偏差 | I法24 h尿钠排泄量估测值的相对偏差 | T法24 h尿钠排泄量估测值的相对偏差 |
---|---|---|---|---|
<6.0 g组 | 40 | -144.69 | -68.54 | -105.25 |
6.0~8.9 g组 | 51 | -63.17 | -1.59 | -28.09 |
9.0~11.9 g组 | 58 | -38.23 | 11.37 | -5.21 |
≥12 g组 | 47 | 12.18 | 38.27 | 35.13 |
Table 9 The relative difference between the estimated 24-hour sodium excretion by three estimation methods and the measured 24-hour sodium excretion
钠盐摄入量 | 例数 | K法24 h尿钠排泄量估测值的相对偏差 | I法24 h尿钠排泄量估测值的相对偏差 | T法24 h尿钠排泄量估测值的相对偏差 |
---|---|---|---|---|
<6.0 g组 | 40 | -144.69 | -68.54 | -105.25 |
6.0~8.9 g组 | 51 | -63.17 | -1.59 | -28.09 |
9.0~11.9 g组 | 58 | -38.23 | 11.37 | -5.21 |
≥12 g组 | 47 | 12.18 | 38.27 | 35.13 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
|
[10] |
|
[11] |
|
[12] |
|
[13] |
杜晓甫,陈向宇,张洁,等. 三种点尿法估算中国人群24 h尿钠排泄量的可行性评价[J]. 中华预防医学杂志,2020,54(4):420-424. DOI:10.3760/cma.j.cn112150-20190610-00458.
|
[14] |
|
[15] |
|
[16] |
国家卫生健康委员会. 中国居民营养与慢性病状况报告-2020年[M]. 北京:人民卫生出版社,2021.
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
|
[22] |
姜薇,张俊仕,帕提古丽,等. 点尿法及24h尿收集法估算高血压病患者24 h尿钠钾排泄量的应用比较[J]. 中华诊断学电子杂志,2019,7(1):21-25. DOI:10.3877/cma.j.issn.2095-655X.2019.01.005.
|
[23] |
|
[24] |
|
[1] | LIANG Keke, GUO Qingge, LI Xiaohuan, MA Jianjun, YANG Hongqi, SHI Xiaoxue, FAN Yongyan, YANG Dawei, GUO Dashuai, DONG Linrui, GU Qi, LI Dongsheng. Predictive Value of Machine Learning Based on Retinal Structural Changes for Early Parkinson's Disease Diagnosis [J]. Chinese General Practice, 2024, 27(09): 1102-1108. |
[2] | DONG Na, CUI Ting, WANG Lulu, SHI Ronghui, FENG Jie, HUANG Xiaojun. Research Trends in Artificial Intelligence in Gastric Cancer Diagnosis and Treatment: a 20-year Bibliometric Analysis [J]. Chinese General Practice, 2024, 27(04): 493-501. |
[3] | Holistic Health Coordination Group of the Psychosomatic Medicine Society of the Chinese Medical Association. Chinese Expert Consensus on Diagnosis and Treatment of Psychiatric Dizziness [J]. Chinese General Practice, 2024, 27(02): 125-131. |
[4] | NAN Ziqing, LIN li. Progress in the Diagnosis and Treatment of Urinary Retention during Pregnancy [J]. Chinese General Practice, 2023, 26(36): 4608-4612. |
[5] | Expert Consensus Writing Group of Integrated Traditional Chinese and Western Medicine Management for Chronic Obstructive Pulmonary Disease. Expert Consensus on Integrated Traditional Chinese and Western Medicine Management for Chronic Obstructive Pulmonary Disease (2023 Edition) [J]. Chinese General Practice, 2023, 26(35): 4359-4371. |
[6] | HONG Yuchun, WU Hua, DU Yishan, LI Shuran, SUN Wenmin, YE Mingyu, ZHANG Yongjian, LI Yang. Development of General Practice Diagnostic Terminology and Coding and Empirical Study on Its Application [J]. Chinese General Practice, 2023, 26(31): 3896-3901. |
[7] | CHEN Jing, ZOU Tao, ZHAO Danqing, XIAO Ziwen, WU Xianqing, Chinese Medical Association Psychosomatic Medicine Branch Perinatal Mental Disorders Collaborative Group. Expert Consensus on Screening, Diagnosis and Treatment of Perinatal Mental Disorders [J]. Chinese General Practice, 2023, 26(28): 3463-3470. |
[8] | YIN Zhaoxia, KONG Chongyu, ZOU Xianhui, LI Chuang, HUANG Yin, FENG Yang, WANG Yunfei, GONG Weijie. Traditional Chinese Medicine Disease Spectrum Analysis in Outpatient Clinics of Contracted Residents by Family Doctors in Shenzhen Community Health Service Centers [J]. Chinese General Practice, 2023, 26(25): 3112-3117. |
[9] | ZHANG Yunxu, WANG Tingting, WEI Junling, XING Yanyun, SU Li. A Newly Discovered Disease Affecting Women's Physical and Mental Health: Research Status and Expert Consensus Interpretation of Persistent Genital Arousal Disorder [J]. Chinese General Practice, 2023, 26(23): 2830-2835. |
[10] | ZHANG Yanjing, SONG Xiaokun. Ideas for the Diagnosis and Treatment of Multisystem Immune-related Adverse Events Caused by Immune Checkpoint Inhibitors [J]. Chinese General Practice, 2023, 26(23): 2930-2935. |
[11] | HU Xiaofei, ZHAO Ping, CAO Tinghua, PENG Lanlan. Study on the Predictive Value of Abdominal Fat Content and Distribution in the Acute Pancreatitis and Its Severity [J]. Chinese General Practice, 2023, 26(21): 2614-2619. |
[12] | SHEN Junxi, ZHU Xing, CHEN Yunzhi, LI Wen. Novel Developments in Lung and Gut Microbiota and Their Cross-talk with the Development of Chronic Obstructive Pulmonary Disease [J]. Chinese General Practice, 2023, 26(20): 2548-2554. |
[13] | REN Yumei, XU Min, YE Meilei, ZHANG Qiu, HU Honglin. A Mutation in the Insulin Receptor Substrate 2 Gene May Be Associated with Maturity-onset Diabetes of the Young: a Case Report with Genetic Analysis [J]. Chinese General Practice, 2023, 26(18): 2301-2305. |
[14] | WANG Hai, WANG Zhuoli, PEI Honghong, PAN Longfei. Analysis of Risk Factors and Exploration of Predictors of Serious Cases of COVID-19 in Xi'an during the Period of 2021-2022 [J]. Chinese General Practice, 2023, 26(17): 2132-2137. |
[15] | XU Bixia, YAO Weiguang. Changes in Patient Visits and Associated Determinants in Primary Healthcare Settings in Guangdong: a Grey Relational Analysis [J]. Chinese General Practice, 2023, 26(16): 1965-1971. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||